Biotech

All Articles

' Professional instinct' led FDA experts to support Zevra's uncommon ailment med

.Zevra Therapies' unusual health condition medication appears to become on the course to approval th...

Pfizer takes $230M attacked after axing neglected DMD gene therapy

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) gene treatment breakdown has actually gone a $230 ...

AC Immune observes 'site' prospective in Alzheimer's medicine data

.After much more than twenty years of work with neurodegenerative diseases, Swiss biotech a/c Immune...

GSK loses ph. 2 HPV vaccination over shortage of best-in-class prospective

.GSK has actually ditched a period 2 human papillomavirus (HPV) injection from its own pipe after ma...

OS Treatments refiles $6M IPO to finance HER2 medication, preclinical ADCs

.OS Therapies will provide on the NYSE American stock exchange today by means of a $6.4 million IPO ...

ALX's fizzling CD47 action rate delivers inventory spiraling down

.ALX Oncology's period 2 gastric cancer cells feedback cost has deteriorated. After observing its ow...

Ionis centers eye health condition from intendeds of Roche-partnered possibility after information disappoint

.Yet Another of Ionis Pharmaceuticals' key midphase readouts has actually disappointed assumptions, ...

Biogen's chief executive officer pointed out no risky deals in 2023. He's ready to be daring

.While Biogen's pharma peers are actually looking for late-stage possessions with little danger, chi...

Instil refills pipe in $2B biobucks handle ImmunOnco

.Instil Biography has actually been actually a biotech searching for a pipe after it ditched its own...

Biogen walks away from Denali Alzheimer's collab

.Biogen has actually returned liberties to an early Alzheimer's condition system to Denali Therapeut...